Gene Weaver awarded Gates Foundation grant for programmable gene insertion platform - Pharmafile

▤ Summary

Gene Weaver secured a $515,000 grant from the Bill and Melinda Gates Foundation to advance its programmable gene insertion technology. The platform targets precise and permanent gene edits in mammalian cells, including large sequence insertions. Gene Weaver says the system could improve production of affordable protein therapeutics for low- and middle-income countries. The company aims to address current gene editing limits such as payload size, integration variability, and manufacturing scalability.

$ Funding

▦ Linked Companies